orforglipron: Clinical Trials

2 trials of orforglipron, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow orforglipron: new trials by email Literature Review of orforglipron trials Research Report on orforglipron

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
LY3502970, Placebo - Obesity, Overweight and Obesity
Phase 2CompletedEli Lilly and Company2722021-09-292023-09-13
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
LY3502970, Dulaglutide, Placebo - Type 2 Diabetes
Phase 2CompletedEli Lilly and Company3832021-09-152023-10-17

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Obesity (1)  ·  Overweight (1)

Sponsors

Eli Lilly and Company (2)

Countries

Hungary (2)  ·  Puerto Rico (2)  ·  United States (2)  ·  Canada (1)  ·  Poland (1)  ·  Slovakia (1)

Results publications

PMID 40481478, PMID 37351564, PMID 37369232